SCHEMBL6651604

SCHEMBL6651604

CCCCCOc1ccccc1OCCCCC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.63
CYP2C9 P11712 1/20 0.63
CYP2C19 P33261 1/20 0.63
MAPT P10636 2/20 0.59
CYP3A4 P08684 2/20 0.59
MEN1 O00255 1/20 0.59
NR1I2 O75469 1/20 0.59
LMNA P02545 1/20 0.59
CHRM2 P08172 1/20 0.59
ADRA2A P08913 1/20 0.59
OPRK1 P41145 1/20 0.59
HTR2B P41595 1/20 0.59
SLC6A3 Q01959 1/20 0.59
KMT2A Q03164 1/20 0.59
HDAC6 Q9UBN7 1/20 0.59
L3MBTL1 Q9Y468 4/20 0.59
LTA4H P09960 1/20 0.55
TDP1 Q9NUW8 1/20 0.53
ALDH1A1 P00352 2/20 0.52
MCHR1 Q99705 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30096940 1.00 CYP1A2 (0.63) CYP1A2CYP2C9CYP2C19MAPTCYP3A4
SCHEMBL2245919 0.98 LMNA (0.62) CYP1A2CYP2C9CYP2C19MAPTCYP3A4
SCHEMBL9387360 0.98 LMNA (0.62) CYP1A2CYP2C9CYP2C19MAPTCYP3A4
SCHEMBL30620186 0.98 LMNA (0.62) CYP1A2CYP2C9CYP2C19MAPTCYP3A4
SCHEMBL9394792 0.98 LMNA (0.62) CYP1A2CYP2C9CYP2C19MAPTCYP3A4
SCHEMBL2859001 0.98 LMNA (0.62) CYP1A2CYP2C9CYP2C19MAPTCYP3A4
SCHEMBL30292285 0.98 LMNA (0.62) CYP1A2CYP2C9CYP2C19MAPTCYP3A4
SCHEMBL1778134 0.98 LMNA (0.62) CYP1A2CYP2C9CYP2C19MAPTCYP3A4
SCHEMBL1964196 0.98 LMNA (0.62) CYP1A2CYP2C9CYP2C19MAPTCYP3A4
SCHEMBL29868324 0.98 LMNA (0.62) CYP1A2CYP2C9CYP2C19MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250276107-A1 HYDROGEL SYSTEMS AND METHODS FOR TREATING FISTULA AND OTHER INDICATIONS TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION (US) 2025-09-04 US claimed
CN-117964812-A Alkoxy magnesium particles, and corresponding catalyst solid component and catalyst system thereof 中国石油化工股份有限公司 2024-05-03 CN claimed
CN-117964813-A Solid catalyst component and catalyst system for olefin polymerization and preparation method thereof 中国石油化工股份有限公司 2024-05-03 CN claimed
CN-117964814-A Ziegler-Natta solid catalyst component, catalyst and application thereof 中国石油化工股份有限公司 2024-05-03 CN claimed
CN-115385796-A Benzophenanthrene charge transfer compound and synthesis method thereof 北京印刷学院 2022-11-25 CN claimed
US-20250276107-A1 HYDROGEL SYSTEMS AND METHODS FOR TREATING FISTULA AND OTHER INDICATIONS TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION (US) 2025-09-04 US disclosed
CN-117964814-A Ziegler-Natta solid catalyst component, catalyst and application thereof 中国石油化工股份有限公司 2024-05-03 CN disclosed
CN-117964812-A Alkoxy magnesium particles, and corresponding catalyst solid component and catalyst system thereof 中国石油化工股份有限公司 2024-05-03 CN disclosed
CN-117964813-A Solid catalyst component and catalyst system for olefin polymerization and preparation method thereof 中国石油化工股份有限公司 2024-05-03 CN disclosed
CN-117836300-A Intelligent covalent organic framework and method for carbon dioxide adsorption induced switchable antibacterial activity 科学与工业研究会(按照印度社会团体注册法案(1860年第21号法案)设立的注册机构) 2024-04-05 CN disclosed
CN-115650856-A Benzophenanthrene derivative-based charge transfer complex and preparation method thereof 北京印刷学院 2023-01-31 CN disclosed
CN-115385796-A Benzophenanthrene charge transfer compound and synthesis method thereof 北京印刷学院 2022-11-25 CN disclosed
US-20070167614-A1 Organic opto-electronic polymer and use thereof ETERNAL CHEMICAL CO., LTD. 2007-07-19 US disclosed
EP-1159649-B1 ELECTRON BEAM RESIST NAT INST OF ADVANCED IND SCIEN (JP) 2004-06-09 EP disclosed
US-6503688-B1 A coating layer containing a polysubstituted triphenylene compound on the substrate surface, the polysubstituted triphenylene compound being an electron beam resist material THE UNIVERSITY OF BIRMINGHAM (GB) 2003-01-07 US disclosed
US-5424280-A Aryloxybenzene herbicidal agents AMERICAN CYANAMID COMPANY (US) 1995-06-13 US disclosed
EP-0647612-A1 Aryloxybenzene herbicidal agents AMERICAN CYANAMID COMPANY (US) 1995-04-12 EP disclosed
US-4681941-A Method of preparing esters of aryloxyphenoxy propanoic acid THE DOW CHEMICAL COMPANY (US) 1987-07-21 US disclosed
EP-0128658-B1 IMPROVED METHOD OF PREPARING ESTERS OF ARYLOXYPHENOXY PROPANOIC ACID THE DOW CHEMICAL COMPANY (US) 1987-06-16 EP disclosed
EP-0128658-A1 Improved method of preparing esters of aryloxyphenoxy propanoic acid THE DOW CHEMICAL COMPANY (US) 1984-12-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167614-A1 Organic opto-electronic polymer and use thereof PPOX, CYBA, OGFOD1 CYP1A2 1482/4885CYP2C9 1059/4885CYP2C19 437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.